Baxter, CSL, Grifols are the leaders of the industry, with 71% market share, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
North America is the largest sales place, with a consumption value market share nearly 39%. Following North America, Europe is the second largest sales place with the revenue market share of 25%. China is an important market of Blood Product in Asia, accounting for 14% revenue market share of global market.
The global Plasma Fractionation market was valued at US$ 26040 million in 2020 and is expected to reach US$ 41450 million by the end of 2027, growing at a CAGR of 6.8% during 2021-2027.
This report focuses on Plasma Fractionation volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Plasma Fractionation market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Plasma Fractionation Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Segment by Application
Middle East & Africa
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region